Publication:
Extracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome.

dc.contributor.authorCruz, Francisco Miguel
dc.contributor.authorMacias, Alvaro
dc.contributor.authorMoreno-Manuel, Ana I
dc.contributor.authorGutiérrez, Lilian K
dc.contributor.authorVera-Pedrosa, María Linarejos
dc.contributor.authorMartinez-Carrascoso, Isabel
dc.contributor.authorSánchez Pérez, Patricia
dc.contributor.authorRuiz Robles, Juan Manuel
dc.contributor.authorBermúdez-Jiménez, Francisco J
dc.contributor.authorDíaz-Agustín, Aitor
dc.contributor.authorMartínez de Benito, Fernando
dc.contributor.authorArias-Santiago, Salvador
dc.contributor.authorBraza-Boils, Aitana
dc.contributor.authorMartín-Martínez, Mercedes
dc.contributor.authorGutierrez-Rodríguez, Marta
dc.contributor.authorBernal, Juan Antonio
dc.contributor.authorZorio, Esther
dc.contributor.authorJiménez-Jaimez, Juan
dc.contributor.authorJalife, Jose
dc.contributor.funderNational Institutes of Health (Estados Unidos)es_ES
dc.contributor.funderFundación La Caixaes_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)es_ES
dc.contributor.funderFundación La Marató TV3es_ES
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERCV (Enfermedades Cardiovasculares)es_ES
dc.contributor.funderUnión Europea. Comisión Europea. H2020es_ES
dc.contributor.funderComunidad de Madrid (España)es_ES
dc.contributor.funderMinisterio de Universidades (España)es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.date.accessioned2024-05-22T10:34:51Z
dc.date.available2024-05-22T10:34:51Z
dc.date.issued2024-04-12
dc.description.abstractBACKGROUND Andersen-Tawil syndrome type 1 is a rare heritable disease caused by mutations in the gene coding the strong inwardly rectifying K+ channel Kir2.1. The extracellular Cys (cysteine)122-to-Cys154 disulfide bond in the channel structure is crucial for proper folding but has not been associated with correct channel function at the membrane. We evaluated whether a human mutation at the Cys122-to-Cys154 disulfide bridge leads to Kir2.1 channel dysfunction and arrhythmias by reorganizing the overall Kir2.1 channel structure and destabilizing its open state. METHODS We identified a Kir2.1 loss-of-function mutation (c.366 A>T; p.Cys122Tyr) in an ATS1 family. To investigate its pathophysiological implications, we generated an AAV9-mediated cardiac-specific mouse model expressing the Kir2.1C122Y variant. We employed a multidisciplinary approach, integrating patch clamping and intracardiac stimulation, molecular biology techniques, molecular dynamics, and bioluminescence resonance energy transfer experiments. RESULTS Kir2.1C122Y mice recapitulated the ECG features of ATS1 independently of sex, including corrected QT prolongation, conduction defects, and increased arrhythmia susceptibility. Isolated Kir2.1C122Y cardiomyocytes showed significantly reduced inwardly rectifier K+ (IK1) and inward Na+ (INa) current densities independently of normal trafficking. Molecular dynamics predicted that the C122Y mutation provoked a conformational change over the 2000-ns simulation, characterized by a greater loss of hydrogen bonds between Kir2.1 and phosphatidylinositol 4,5-bisphosphate than wild type (WT). Therefore, the phosphatidylinositol 4,5-bisphosphate-binding pocket was destabilized, resulting in a lower conductance state compared with WT. Accordingly, on inside-out patch clamping, the C122Y mutation significantly blunted Kir2.1 sensitivity to increasing phosphatidylinositol 4,5-bisphosphate concentrations. In addition, the Kir2.1C122Y mutation resulted in channelosome degradation, demonstrating temporal instability of both Kir2.1 and NaV1.5 proteins. CONCLUSIONS The extracellular Cys122-to-Cys154 disulfide bond in the tridimensional Kir2.1 channel structure is essential for the channel function. We demonstrate that breaking disulfide bonds in the extracellular domain disrupts phosphatidylinositol 4,5-bisphosphate-dependent regulation, leading to channel dysfunction and defects in Kir2.1 energetic stability. The mutation also alters functional expression of the NaV1.5 channel and ultimately leads to conduction disturbances and life-threatening arrhythmia characteristic of Andersen-Tawil syndrome type 1.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe authors thank the Centro Nacional de Investigaciones Cardiovasculares (CNIC) Viral Vectors Unit for producing the adeno-associated virus serotype 9. Confocal experiments were conducted at the CNIC Microscopy and Dynamic Imaging Unit. The authors thank the CNIC Bioinformatics Unit for generating the in silico homology modeling simulations, F-function analysis, and helpful discussions. The authors also thank the Centro de Supercomputación de Galicia for the use of the Finis Terrae III supercomputer to perform molecular dynamics studies. The CNIC was supported by the Instituto de Salud Carlos III, the Ministerio de Ciencia, Innovación y Universidades, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (grant CEX2020-001041-S funded by MICIU/AEI/10.13039/501100011033). This work was supported by the National heart, Lung and Blood Institute under National Institutes of Health (NIH) grant R01HL163943; the La Caixa Banking Foundation project code HR18-00304 (grant LCF/PR/HR19/52160013); grants PI-FIS-2020, PI20/01220, PI-FIS-2023, and PI23/01039 from the Instituto de Salud Carlos III and cofunded by the Fondo Europeo de Desarrollo Regional (FEDER) and the European Union, respectively; grants PID2020-116935RB-I00 and BFU2016-75144-R funded by MICIU/AEI/10.13039/501100011033; the Fundación La Marató de TV3 (736/C/2020) amb el suport de la Fundació La Marató de TV3; the CIBER (Centro de Investigación Biomédica en Red) de Enfermedades Cardiovasculares (grant CB16/11/00458); the European Union’s Horizon 2020 grant agreement GA-965286; and the Program S2022/BMD7229-CM ARCADIACM funded by the Comunidad de Madrid to J. Jalife; grant PID2021-126423OB-C22 (to M. Martín-Martínez) funded by MICIU/AEI/10.13039/501100011033; and European Regional Development Fund (ERDF) grant PID2022-137214OB-C22 (to M. Gutierrez-Rodríguez) funded by MICIU/AEI/10.13039/501100011033. The imaging studies were performed in the TRIMA@CNIC (Infraestructura de Imagen Traslacional Avanzada del CNIC) node of the ICTS ReDIB (Infraestructuras Científicas y Técnicas Singulares: Red Distribuida de Imagen Biomédica) grant ICTS-2018- 04-CNIC-16 funded by MICIU/AEI/10.13039/501100011033 and ERDF, and project EQC2018-005070-P funded by MICIU/AEI/10.13039/501100011033 and FEDER. A.I. Moreno-Manuel holds an formación profesional universitaria (FPU) contract (FPU20/01569) from the Ministerio de Universidades. J.M. Ruiz Robles holds an FPU contract (FPU22/03253) from the Ministerio de Universidades. L.K. Gutiérrez holds an FPI contract (PRE2018-083530) from the Ministerio de Economía y Competitividad de España cofunded by the Fondo Social Europeo, attached to project SEV-2015-0505-18-2. I. Martínez-Carrascoso holds a PFIS (Contratos predoctorales de formación en investigación en salud) contract (FI21/00243) funded by Instituto de Salud Carlos III and the Fondo Social Europeo Plus cofunded by the European Union. M.L. Vera-Pedrosa held contract PEJD-2019-PRE/BMD15982 funded by the Consejería de Educación e Investigación de la Comunidad de Madrid y Fondo Social Europeo.es_ES
dc.format.number8es_ES
dc.format.pagee52es_ES
dc.format.volume134es_ES
dc.identifier.citationCirc Res. 2024 Apr 12;134(8):e52-e71.es_ES
dc.identifier.doi10.1161/CIRCRESAHA.123.323895es_ES
dc.identifier.e-issn1524-4571es_ES
dc.identifier.journalCirculation researches_ES
dc.identifier.pubmedID38497220es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/19523
dc.language.isoenges_ES
dc.publisherLippincott Williams & Wilkins (LWW)es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MICIU/AEI/10.13039/501100011033es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/MICIU/AEI/10.13039/501100011033/CEX2020-001041-Ses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2020-116935RB-I00es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/BFU2016-75144-Res_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/TV3/736/C/2020es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CB16/11/00458es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/S2022/BMD7229-CMes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021-126423OB-C22es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2022-137214OB-C22es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/ICTS-2018-04-CNIC-16es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/EQC2018-005070-Pes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FPU20/01569es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FPU22/03253es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PRE2018-083530es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SEV-2015-0505-18-2es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FI21/00243es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PEJD-2019-PRE/BMD15982es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/GA-965286es_ES
dc.relation.publisherversion10.1161/CIRCRESAHA.123.323895es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación:: Arritmias Cardíacases_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshAndersen Syndromees_ES
dc.subject.meshHumanses_ES
dc.subject.meshMicees_ES
dc.subject.meshAnimalses_ES
dc.subject.meshMutationes_ES
dc.subject.meshMyocytes, Cardiaces_ES
dc.subject.meshCardiac Conduction System Diseasees_ES
dc.subject.meshDisulfideses_ES
dc.subject.meshPhosphatidylinositolses_ES
dc.titleExtracellular Kir2.1C122Y Mutant Upsets Kir2.1-PIP2 Bonds and Is Arrhythmogenic in Andersen-Tawil Syndrome.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication476df8e6-869f-4952-9b04-8c78580b6b14
relation.isAuthorOfPublication7c2c2e05-243f-40b8-a1b5-e6ae3a0b5d5a
relation.isAuthorOfPublication1eb7795b-8c51-47a4-bf71-37bdf11c46c7
relation.isAuthorOfPublication2ce72629-a066-40f8-ad95-1a476ff6aa77
relation.isAuthorOfPublication3281dd95-3aa7-46b8-857c-aca343b747c0
relation.isAuthorOfPublication.latestForDiscovery476df8e6-869f-4952-9b04-8c78580b6b14

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Extracellular-kir2-1c122y_Extracellular_Circ Res_2024.pdf
Size:
16.14 MB
Format:
Adobe Portable Document Format
Description:
Artículo